| VTR |
Report |
Normalized FFO/share (2026 Q2) |
BEAT |
pred ~$0.97 vs. cons $0.96 |
MEDIUM |
| VTR |
Report |
Revenue (2026 Q2) |
BEAT |
pred ~$1.70B vs. cons $1.68B |
MEDIUM |
| VTR |
Report |
SHOP same-store cash NOI growth (2026 Q2) |
BEAT |
pred ~16.2% vs. cons 15.5% |
MEDIUM |
| VTR |
Guide |
Normalized FFO/share guidance |
BETTER |
guide ~$3.90 midpoint vs. cons $3.88 (FY2026) |
MEDIUM |
| VTR |
Guide |
SHOP same-store cash NOI growth guidance |
BETTER |
guide ~16.5% midpoint vs. cons 16.0% (FY2026) |
MEDIUM |
| VTR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.2% |
— |
LOW |
| VTR |
Return |
5-day cumulative residual |
+1.3% (FADE) |
The initial operating beat and guidance raise should support the stock, but FY2026 guidance of ~$3.90 versus consensus of $3.88 implies only ~$1.99 of second-half FFO versus consensus near $1.98; limited out-period estimate upside and the premium valuation should cause part of the day-1 gain to fade. |
LOW |